` 089140 (NexturnBioScience Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

N
089140
vs
K
KOSPI 200

Over the past 12 months, NexturnBioScience Co Ltd has underperformed KOSPI 200, delivering a return of -9% compared to the KOSPI 200's +123% growth.

Stocks Performance
089140 vs KOSPI 200

Loading
089140
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
089140 vs KOSPI 200

Loading
089140
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
089140 vs KOSPI 200

Loading
089140
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
NexturnBioScience Co Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

NexturnBioScience Co Ltd
Glance View

Market Cap
32.6B KRW
Industry
Machinery

NEXTURNBIOSCIENCE Co., Ltd. engages in the manufacture and sale of thermoforming equipment and computer numerical control (CNC) lathes. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2006-11-01. The firm's products are used for automobile parts such as engine parts, steering devices, wipers and others, marine engine parts, medical devices and implants, communication equipment such as mobile phones, digital multimedia broadcasting (DMB) devices and others, electronic components such as liquid crystal display (LCD), copier, printer and others, hydraulic and pneumatic parts, among others. The company also provides related parts, after-sales service.

Intrinsic Value
2 920.5 KRW
Undervaluation 27%
Intrinsic Value
Price ₩2 130
N
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett